Top compounds associated with response to MYLPF


Feature Type Standardized
Nominal ANOVA
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.057 0.09
mRNA AZD8055 GDSC1000 pan-cancer AAC -0.057 0.09
mRNA lovastatin CTRPv2 pan-cancer AAC -0.06 0.1
mRNA etoposide GDSC1000 pan-cancer AAC -0.059 0.1
mRNA SB590885 GDSC1000 pan-cancer AAC -0.055 0.1
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.26 0.1
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.058 0.1
mRNA tosedostat CTRPv2 pan-cancer AAC -0.058 0.1
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.075 0.1
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.063 0.1
Download CSV